Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2011 | 03-2011 | 12-2010 | 09-2010 | 06-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 137,279 | 104,354 | 128,763 | 82,832 | 93,618 |
| Receivables | 116,179 | 106,117 | 106,005 | 107,150 | 97,779 |
| Inventories | 174,460 | 154,601 | 146,928 | 147,973 | 143,253 |
| Income taxes - deferred | 35,072 | 35,306 | 35,284 | 29,839 | 29,526 |
| TOTAL | $495,784 | $425,185 | $444,849 | $386,295 | $387,631 |
| Non-Current Assets | |||||
| PPE Net | 115,667 | 102,478 | 99,456 | 87,293 | 84,644 |
| Intangibles | 516,311 | 458,636 | 456,832 | 461,144 | 453,317 |
| Other Non-Current Assets | 26,094 | 20,729 | 17,996 | 24,544 | 16,203 |
| TOTAL | $658,072 | $581,843 | $574,284 | $572,981 | $554,164 |
| Total Assets | $1,153,856 | $1,007,028 | $1,019,133 | $959,276 | $941,795 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 7,500 | N/A |
| Accounts payable and accrued liabilities | 47,894 | 35,311 | 27,783 | 34,719 | 32,906 |
| Accrued Expenses | 66,747 | 54,794 | 61,192 | 56,158 | 48,732 |
| TOTAL | $118,008 | $163,316 | $201,857 | $102,704 | $85,639 |
| Non-Current Liabilities | |||||
| Long Term Debt | 144,375 | 136,875 | 139,688 | 212,500 | 220,000 |
| Deferred Revenues | 3,367 | 3,836 | 4,444 | 4,327 | 4,001 |
| Other Non-Current Liabilities | 362,339 | 168,432 | 166,980 | 165,999 | 168,125 |
| TOTAL | $517,031 | $316,126 | $317,313 | $385,772 | $395,780 |
| Total Liabilities | $635,039 | $479,442 | $519,170 | $488,476 | $481,419 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 55,035 | 57,122 | 57,208 | 56,513 | 58,156 |
| Common Shares | 360 | 359 | 355 | 354 | 353 |
| Retained earnings | 245,018 | 244,317 | 232,830 | 214,024 | 197,540 |
| Other shareholders' equity | 16,190 | 12,383 | -1,453 | 1,771 | -19,380 |
| TOTAL | $518,817 | $527,586 | $499,963 | $470,800 | $460,376 |
| Total Liabilities And Equity | $1,153,856 | $1,007,028 | $1,019,133 | $959,276 | $941,795 |